mergers and acquisitions2 min read
Exclusive: OpenAI has acquired Orchestra Bio
OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.
By Madison MillsAxios AI+

Read the full story
Originally published by Axios AI+ on Oct 20, 2026.
Comments
Sign in to join the discussion.